SCHEMBL1805649

SCHEMBL1805649

C1=CCC(CC2=C3CCC(C3)C2)=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3993707 0.69
SCHEMBL8671020 0.66
SCHEMBL9064044 0.66
Iodide SCHEMBL9167652 0.65
Bromide SCHEMBL9169681 0.65
Bromide SCHEMBL9169684 0.65
Hydrochloric Acid SCHEMBL9164462 0.65
Hydrochloric Acid SCHEMBL9164467 0.65
Bromide SCHEMBL9164400 0.65
Iodide SCHEMBL9169108 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11833255-B2 Nanoparticles with pH triggered drug release THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) 2023-12-05 US claimed
US-20200206145-A1 Amphiphile-Polymer Particles NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2020-07-02 US claimed
US-20180318230-A1 Nanoparticles with pH Triggered Drug Release THE BRIGHAM AND WOMEN'S HOSPITAL, INC. 2018-11-08 US claimed
US-20170304213-A1 Amphiphile-Polymer Particles PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2017-10-26 US claimed
US-20170216218-A1 Nanoparticles and Methods of Use PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2017-08-03 US claimed
WO-2016061201-A1 NANOPARTICLES AND METHODS OF USE THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) 2016-04-21 WO claimed
EP-2469285-A1 Water soluble metal and semiconductor nanoparticle complexes The Rockefeller University (US) 2012-06-27 EP claimed
US-20040033345-A1 Hydrophilic shell and a hydrophobic core having a hydrophobic chain comprising a minimum of 8 atoms; wherein the total number of atoms in all chains for each moiety comprises at least 24 atoms ROCKEFELLER UNIVERSITY, THE 2004-02-19 US claimed
US-12006510-B2 Perfusion culturing methods and uses thereof GENZYME CORPORATION (US) 2024-06-11 US disclosed
WO-2024113009-A1 AGENTS, COMPOSITIONS AND METHODS FOR MODULATING IMMUNITY THE UNIVERSITY OF QUEENSLAND (AU) 2024-06-06 WO disclosed
US-11833255-B2 Nanoparticles with pH triggered drug release THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) 2023-12-05 US disclosed
WO-2023107574-A2 LIPID-BASED COMPOSITIONS AND METHODS THEREOF THE BRIGHAM AND WOMEN’S HOSPITAL, INC. (US) 2023-06-15 WO disclosed
US-20220062428-A1 Prodrugs with a tridentate self-immolative linker THE GENERAL HOSPITAL CORPORATION 2022-03-03 US disclosed
US-20220016271-A1 METHODS FOR TREATING CANCER NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2022-01-20 US disclosed
US-20060167147-A1 Metal-containing composite materials BLUE MEMBRANES GMBH 2006-07-27 US disclosed
WO-2006077256-A1 METAL CONTAINING COMPOSITE MATERIALS CINVENTION AG (DE) 2006-07-27 WO disclosed
WO-2006069677-A2 COMBINATION COMPRISING AN AGENT PROVIDING A SIGNAL, AN IMPLANT MATERIAL AND A DRUG CINVENTION AG (DE) 2006-07-06 WO disclosed
EP-1579506-A2 WATER SOLUBLE METAL AND SEMICONDUCTOR NANOPARTICLE COMPLEXES THE ROCKEFELLER UNIVERSITY (US) 2005-09-28 EP disclosed
WO-2004064109-A2 WATER SOLUBLE METAL AND SEMICONDUCTOR NANOPARTICLE COMPLEXES THE ROCKEFELLER UNIVERSITY (US) 2004-07-29 WO disclosed
US-20040033345-A1 Hydrophilic shell and a hydrophobic core having a hydrophobic chain comprising a minimum of 8 atoms; wherein the total number of atoms in all chains for each moiety comprises at least 24 atoms ROCKEFELLER UNIVERSITY, THE 2004-02-19 US disclosed